Close Menu
  • News
  • Medical
  • Technology
  • Nanomaterials
  • Research
  • Blog
    • Nasiol.com
  • Contact
    • Tech7685@gmail.com
What's Hot

Depositing quantum dots on corrugated chips improves photodetector capabilities

May 8, 2025

Ultrasonic nanocrystal surface modification restores stainless steel’s corrosion resistance

May 7, 2025

Structure dictates effectiveness and safety in nanomedicine, driving therapeutic innovation, say scientists

May 7, 2025
Facebook X (Twitter) Instagram
Nanotech – Nanomaterials | Medical | Research | News Stories Updated Daily Nanotech – Nanomaterials | Medical | Research | News Stories Updated Daily
  • News
  • Medical
  • Technology
  • Nanomaterials
  • Research
  • Blog
    • Nasiol.com
  • Contact
    • Tech7685@gmail.com
Facebook X (Twitter) Instagram
Nanotech – Nanomaterials | Medical | Research | News Stories Updated Daily Nanotech – Nanomaterials | Medical | Research | News Stories Updated Daily
Home»Research»Advancing the Frontiers of Cancer Treatment: Tel Aviv University’s Groundbreaking RNA Therapy for Multiple Myeloma
Research

Advancing the Frontiers of Cancer Treatment: Tel Aviv University’s Groundbreaking RNA Therapy for Multiple Myeloma

August 21, 2023No Comments4 Mins Read
Facebook Twitter Pinterest Telegram LinkedIn Tumblr WhatsApp Email
Advancing the Frontiers of Cancer Treatment: Tel Aviv University’s Groundbreaking RNA Therapy for Multiple Myeloma
Share
Facebook Twitter LinkedIn Pinterest Telegram Email

In the face of the relentless global scourge of multiple myeloma, a blood cancer found typically among the elderly, scientists across the globe are in a frantic search for effective treatments.

This cancer forms tumours within the bone marrow, making it particularly challenging to combat. Patients suffer from severe bone pain, anaemia, kidney failure, and a significantly weakened immune system.

RNA Therapy: A New Frontier in Cancer Treatment

A team of researchers from Tel Aviv University and Rabin Medical Center have offered a glimmer of hope with their groundbreaking RNA-based treatment. Using lipid-based nanoparticles to deliver RNA molecules designed to silence the gene CKAP5, they have achieved staggering results, successfully destroying 90% of multiple myeloma cells under laboratory conditions and 60% in human tissue samples.

This new therapeutic approach is especially promising as it can be tailored quickly to individual patients’ needs. Different genes can be silenced each time by merely adjusting the RNA molecule, creating a custom solution for each patient based on the disease’s progression. Moreover, this therapy is uniquely capable of reaching cancer cells within the bone marrow, a significant advantage over other forms of treatment.

Dana Tarab-Ravski, PhD student involved in the research said, “RNA-based therapy has a great advantage in this case because it can be developed very quickly. By simply changing the RNA molecule, a different gene can be silenced each time, thereby tailoring the treatment to the progression of the disease and to the individual patient. The challenge in these treatments is to reach the right cells.”

This RNA-based therapy can be personalised and can even reach tricky areas like bone marrow, and it’s a big reason why the market for it is expected to grow so much.

See also  Core-Shell Nanoparticles Paving the Way for Sustainable Energy Technologies

According to Research and Markets, the global market size for the RNA-Based Therapeutic Market is anticipated to attain over $11 billion by 2027, exhibiting a remarkable Compound Annual Growth Rate (CAGR) of 15.1% during the forecast period.

Overcoming Obstacles: The Path Ahead for RNA Therapy

While promising, the innovative RNA-based therapy for multiple myeloma confronts a series of challenges before it becomes accessible as a widely used treatment.

Firstly, regulatory hurdles pose a substantial barrier. Treatments must pass rigorous testing and obtain approval from health authorities, such as the FDA or EMA. This comprehensive examination, meant to ensure safety and efficacy, includes multiple stages of trials and can significantly prolong the treatment’s journey to the market.

Secondly, the financial costs associated with drug development are steep. The process involves extensive R&D expenditures, from lab equipment and expert personnel to clinical trials and regulatory procedures. Securing ample funding can often prove to be a daunting task.

Lastly, potential resistance from established pharmaceutical entities may present a challenge. Introducing a new, unproven treatment could disrupt the industry’s status quo, potentially causing pushback from current market leaders.

Despite these challenges, the potential of this therapy has garnered attention in the investment world. Alnylam, with total funding of $17 million, a pioneering company in the healthcare sector, is making significant strides in developing RNA interference-based therapeutics. Their efforts span across a wide array of disorders, showcasing their comprehensive approach to disease management.

A spokesperson for the company said, “Medicines based on RNAi work by “silencing” or disabling the production of the genes that cause specific diseases. In doing so, RNAi therapeutics work “upstream” of most other classes of medicines, such as small molecules and monoclonal antibodies, by targeting the “root” genetic cause of a disease rather than its symptoms.”

See also  Advancing Heat Management in Nanodevices Through Silicon Dioxide Coatings

Conclusion

The development and refinement of RNA-based therapies hold great promise in revolutionising multiple myeloma treatment. The increasing investment in this field enhances the likelihood of overcoming existing challenges and making these innovative therapies more accessible to patients. Continued advancements indicate that the world may be approaching a new era in cancer treatment, presenting significant opportunities for improved patient outcomes and medical advancements.

Source link

Advancing Aviv cancer Frontiers Groundbreaking Multiple Myeloma RNA Tel Therapy Treatment Universitys
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Posts

Carbon nanotube-based strain sensor can detects deformations in multiple directions

May 4, 2025

Nanoparticle treatment combined with radiation therapy significantly improves glioblastoma survival in mice

May 3, 2025

In What Ways Can Nanosensors Be Used to Detect Cancer?

April 22, 2025

Ultra-thin, flexible silicone nanosensor could have huge impact on brain injury treatment

April 22, 2025

AI combined with nanotech can detect oral cancer earlier

April 21, 2025

Label-free fluorosensor detects enteroviral RNA with high selectivity and sensitivity

April 16, 2025

Comments are closed.

Top Articles
News

‘Quartet Nanocage’ vaccine found effective against coronaviruses that haven’t even emerged yet

News

Scientists uncover light absorbing properties of achiral materials

News

The Rise of Antiviral Nanocoatings

Editors Picks

Depositing quantum dots on corrugated chips improves photodetector capabilities

May 8, 2025

Ultrasonic nanocrystal surface modification restores stainless steel’s corrosion resistance

May 7, 2025

Structure dictates effectiveness and safety in nanomedicine, driving therapeutic innovation, say scientists

May 7, 2025

How Can Nanomaterials Be Programmed for Different Applications?

May 6, 2025
About Us
About Us

Your go-to source for the latest nanotechnology breakthroughs. Explore innovations, applications, and implications shaping the future at the molecular level. Stay informed, embrace the nano-revolution.

We're accepting new partnerships right now.

Facebook X (Twitter) Instagram Pinterest
Our Picks

Enhancing adoptive T-cell therapy with nanowire innovation

June 25, 2024

New Uses for Nanotubes in Manufacturing

September 20, 2024

New rapid prototyping method for microscale spiral devices

February 4, 2024

Subscribe to Updates

Get the latest creative Nano Tech news from Elnano.com

© 2025 Elnano.com - All rights reserved.
  • Contact
  • Privacy Policy
  • Terms & Conditions

Type above and press Enter to search. Press Esc to cancel.

Cleantalk Pixel